Getinge B stock trades below its 52-week high

Getinge B stock was trading at SEK 244 on Nasdaq Stockholm on September 24, 2026, down 0.73 percent from the previous close of SEK 245.80. The share price stood 1.77 percent below its 52-week high of SEK 248.40, putting the latest move in a narrow range beneath the yearly peak.

Stock remains near yearly high

The comparison is clear: SEK 244 is SEK 4.40 below the 52-week high, a gap of 1.77 percent. The 52-week low was SEK 175.90, leaving the stock SEK 68.10 above that level and 38.72 percent higher than the low.

Getinge's market capitalization stood at SEK 66,458,177,276 on September 24, 2026. The valuation figure places the company in the large-cap segment of the Swedish market and gives the daily price move a direct equity-market context.

Healthcare portfolio spans three areas

Getinge supplies medical technology for critical healthcare environments. Its activities cover Acute Care Therapies, Life Science and Surgical Workflows, with products used in operating rooms, intensive care and sterile processing.

The company was founded in 1904 and is headquartered in Gothenburg, Sweden. Its portfolio includes equipment for sterilization, bioprocessing, anesthesia, monitoring, ventilation and extracorporeal life support, alongside operating-room infrastructure and surgical systems.

SEK 244 sets the reference point

At 1:48 p.m. CET on September 24, 2026, Getinge B was trading at SEK 244 on Nasdaq Stockholm. The daily change was minus SEK 1.80, or minus 0.73 percent, against the previous close of SEK 245.80.